Early use of convalescent plasma may help outpatients with COVID-19 avoid hospitalization
Nationwide, multicenter clinical trial led by Johns Hopkins shows convalescent plasma works as an early treatment for COVID-19, reducing need for hospitalization by 50%
Source: jhu.edu